EuBiologics relocates headquarters within Seoul’s Gangnam district on Oct. 8

• EuBiologics will relocate its headquarters within Seoul’s Gangnam district on Oct. 8, 2026.
• Move expands office space at the SDBioSensor Building on Dosan-daero 509 to include floors 13-15.
• Relocation driven by headcount growth, aiming to improve the working environment.
• Board decision dated Oct. 6, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EuBiologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006900515), on October 06, 2026, and is solely responsible for the information contained therein.